Endurant Capital Management LP Heron Therapeutics, Inc. Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$4.63 - $9.94 $765,820 - $1.64 Million
-165,404 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$8.35 - $12.6 $1.38 Million - $2.08 Million
165,404 New
165,404 $1.51 Million
Q3 2018

Nov 14, 2018
SELL
$30.0 - $40.85 $264,720 - $360,460
-8,824 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$26.4 - $42.0 $232,953 - $370,608
8,824 New
8,824 $343,000

Others Institutions Holding HRTX

# of Institutions
198
Shares Held
129M
Call Options Held
94.7K
Put Options Held
148K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $236M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email